2.Current status of liver diseases in Korea: Toxic and alcoholic liver diseases.
The Korean Journal of Hepatology 2009;15(Suppl 6):S29-S33
The study of the epidemiology of toxic liver injury has been limited in Korea. The number of hospitalizations for toxic liver injury has been estimated to be 2,400 persons per year. About 30~40% of fulminant hepatitis was attributed to toxic hepatitis. The frequent causative agents of toxic hepatitis in Korea are herbal medicines (34~40%), folk remedies (23~34%), and prescribed medicines (24~55%). However, the most common agents causing severe liver injury including fulminant hepatitis are herbal medicine and folk remedies. Antituberculosis drugs and acetaminophen are two common causes of fulminant hepatitis among prescribed drugs. Alcohol is one of the leading causes of chronic liver disease in Korea. No nationwide study on the epidemiology of alcoholic liver disease (ALD) has been carried out, but 7~31% of cirrhosis has been reported to be alcoholic in a few single-center studies. Alcohol could be a risk factor for the development of hepatocellular carcinoma (HCC) in chronic viral hepatitis. Several studies have shown that alcohol increased the risk of HCC in liver cirrhosis with HBsAg or anti-HCV. Furthermore, alcoholic cirrhosis with occult hepatitis B virus infection increased the risk of HCC.
Drug-Induced Liver Injury/diagnosis/*epidemiology/etiology
;
Humans
;
Korea/epidemiology
;
Liver Cirrhosis, Alcoholic/complications/epidemiology
;
Liver Diseases, Alcoholic/complications/*epidemiology
;
Liver Neoplasms/etiology
;
Risk Factors
3.Analysis of epidemiological characteristics of drug induced liver injury associated with Baixianpi Preparations.
Fei-Lin GE ; Ming NIU ; Zi-Xin HAN ; Yan-Fang ZHANG ; Jia-Bo WANG ; Xiao-He XIAO ; Yu-Ming GUO ; Jun-Ling CAO
China Journal of Chinese Materia Medica 2019;44(5):1048-1052
A retrospective study was performed in drug-induced liver injury(DILI) cases associated with Dictamni Cortex(Baixianpi,BXP) Preparations,which were treated at grade Ⅲ class A liver disease hospitals from 2008 to 2016 and spontaneously reported for adverse reactions between 2012 and 2016 at HILI Cloud(hilicloud.net). The results showed 25 DLII cases associated with BXP Preparations treated at grade Ⅲ class A liver disease hospitals during the 9 years,including only 14 cases in line with the clinical diagnostic criteria of Guidelines for the Diagnosis and Treatment of Herb-Induced Liver Injury. And 74 DILI cases associated with BXP Preparations spontaneously reports adverse reactions,and 18. 92% of them had unreasonable medication,including polypharmacy(21. 43%),overdose(28. 57%) and repeated dosage(50%). And 47 DILI cases used BXP Preparations to treat psoriasis and vitiligo(a total of59. 57%). The time range of taking BXP Preparations until liver injury occurred was 1-366 d,with the median of 18 d. The dose of BXP Preparations was estimated to be 0. 09-12 g·d-1. And the cumulative dosage of taking drugs until liver injury occurred was 1. 1-336 g. Obvious associations with time-toxicity as well as quantity-toxicity could not be found based on the wide range of time-toxicity relations and quantity-toxicity relations. On the basis of the study,we found that DILI cases associated with BXP Preparations commonly occurred in patients with immune diseases,such as psoriasis and vitiligo,indicating specific individual differences. The results suggested that DILI cases associated with BXP Preparations would be correlated with the property of idiosyncratic drug-induced liver injury. In conclusion,the risk of liver injury clinically caused by BXP Preparations should be paid more attention,and the studies on the mechanism of idiosyncratic drug-induced liver injury must be enhanced,and those on risk factors,like irrational drug use,should be strengthened. Moreover,the evaluation of the risk-to-benefit ratio is supposed to be performed for the sake of improving the risk prevention and control standards for BXP preparations,and ensuring safe and rational clinical application of BXP Preparations.
Chemical and Drug Induced Liver Injury
;
epidemiology
;
China
;
Dictamnus
;
chemistry
;
Drugs, Chinese Herbal
;
adverse effects
;
Humans
;
Liver
;
Retrospective Studies
;
Risk Factors
4.Clinical features of drug-induced liver injury in children.
Xin-Xin ZHU ; Yu ZHU ; Chao-Min WAN
Chinese Journal of Contemporary Pediatrics 2012;14(2):131-133
OBJECTIVETo study the clinical features of drug-induced liver injury in children.
METHODSThe clinical data of the hospitalized children with drug-induced liver injury over 5 years were retrospectively reviewed.
RESULTSOf 641 cases of hospitalized children with liver injury, there were 64 cases (10%) of drug induced liver injury. Hepatocellular injury was the most common type of drug-induced liver injury (81%). The major drugs causing drug-induced liver injury included chemotherapy drugs, antibiotics and anti-tuberculosis drugs. Rash (16%), gastrointestinal reaction (15%), fever (14%) and liver intumescence (12%) were common clinical symptoms. A part of patients with drug-induced liver injury (11%) had no symptoms and signs.
CONCLUSIONSDrug-induced liver injury is one of the common causes of liver damage in hospitalized children. Some children with drug-induced liver injury have no symptoms and signs. Hepatocellular injury is a major type of drug-induced liver injury in children, resulting less severe liver damage.
Adolescent ; Chemical and Drug Induced Liver Injury ; diagnosis ; epidemiology ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Retrospective Studies
6.Drug-induced liver injury: present and future.
Clinical and Molecular Hepatology 2012;18(3):249-257
Liver injury due to prescription and nonprescription medications is a growing medical, scientific, and public health problem. Worldwide, the estimated annual incidence rate of drug-induced liver injury (DILI) is 13.9-24.0 per 100,000 inhabitants. DILI is one of the leading causes of acute liver failure in the US. In Korea, the annual extrapolated incidence of cases hospitalized at university hospital is 12/100,000 persons/year. Most cases of DILI are the result of idiosyncratic metabolic responses or unexpected reactions to medication. There is marked geographic variation in relevant agents; antibiotics, anticonvulsants, and psychotropic drugs are the most common offending agents in the West, whereas in Asia, 'herbs' and 'health foods or dietary supplements' are more common. Different medical circumstances also cause discrepancy in definition and classification of DILI between West and Asia. In the concern of causality assessment, the application of the Roussel Uclaf Causality Assessment Method (RUCAM) scale frequently undercounts the cases caused by 'herbs' due to a lack of previous information and incompatible time criteria. Therefore, a more objective and reproducible tool that could be used for the diagnosis of DILI caused by 'herbs' is needed in Asia. In addition, a reporting system similar to the Drug-Induced Liver Injury Network (DILIN) in the US should be established as soon as possible in Asia.
Dietary Supplements/adverse effects
;
Drug-Induced Liver Injury/*diagnosis/epidemiology/*pathology
;
Herbal Medicine
;
Humans
;
Liver Failure, Acute/pathology
;
Prognosis
;
Risk Factors
;
Severity of Illness Index
7.Occupational Hepatic Disorders in Korea.
Hyoung Ryoul KIM ; Tae Woo KIM
Journal of Korean Medical Science 2010;25(Suppl):S36-S40
Occupational hepatic disorders are classified into toxic hepatitis, viral hepatitis, and chemical-induced malignancy in Korea. Toxic hepatitis cases were reported in workers who were exposed to dimethylformamide, dimethylacetamide, or trichloroethylene. Pre-placement medical examination and regular follow-up are necessary to prevent the development of toxic hepatitis. Viral hepatitis was chiefly reported among health care workers such as doctors, nurses and clinical pathology technicians who could easily be exposed to blood. Preventive measures for these groups therefore include vaccination and serum monitoring programs. Hepatic angiosarcoma caused by vinyl chloride monomer (VCM) exposure is a very well known occupational disease and it has not been officially reported in Korea yet. Some cases of hepatocellular carcinoma were legally approved for compensation as an occupational disease largely by overwork and stress, but not supported by enough scientific evidence. Effort to find the evidence of its causal relationship is needed.
Adult
;
Drug-Induced Liver Injury/epidemiology
;
Female
;
Health Personnel
;
Hepatitis, Viral, Human/epidemiology/prevention & control
;
Humans
;
Liver Diseases/*epidemiology/prevention & control
;
Liver Neoplasms/chemically induced/epidemiology
;
Male
;
Middle Aged
;
Occupational Diseases/*chemically induced/*epidemiology/prevention & control
;
Occupational Exposure/adverse effects
;
Republic of Korea/epidemiology
;
Young Adult
8.Mechanisms and management of drug induced liver injury in children.
Chinese Journal of Pediatrics 2014;52(8):583-585
Anti-Bacterial Agents
;
adverse effects
;
Anti-Infective Agents
;
adverse effects
;
Anti-Inflammatory Agents
;
adverse effects
;
Biomarkers
;
blood
;
Chemical and Drug Induced Liver Injury
;
diagnosis
;
epidemiology
;
Child
;
Drug-Related Side Effects and Adverse Reactions
;
Humans
;
Liver
;
drug effects
;
metabolism
;
pathology
;
Pediatrics
;
Risk Factors
9.Chinese herbal medicine induced liver injury.
Chinese Journal of Hepatology 2009;17(6):478-480
Chemical and Drug Induced Liver Injury
;
Cholestasis, Intrahepatic
;
etiology
;
pathology
;
Cytochrome P-450 Enzyme System
;
metabolism
;
Drug Hypersensitivity
;
Drug-Related Side Effects and Adverse Reactions
;
Drugs, Chinese Herbal
;
adverse effects
;
Hepatocytes
;
pathology
;
Humans
;
Liver
;
drug effects
;
metabolism
;
pathology
;
Liver Diseases
;
epidemiology
;
etiology
;
pathology
;
therapy
;
Plants, Medicinal
;
adverse effects
;
chemistry
;
Retrospective Studies
10.Analysis of liver damage and reactivation of hepatitis B virus in hepatitis B surface antigen positive patients after extremely severe burn injury.
Huining BIAN ; Wen LAI ; Shaoyi ZHENG ; Zu'an LIU ; Zhifeng HUANG ; Chuanwei SUN ; Lianghua MA ; Hanhua LI ; Huade CHEN ; Email: GDBURNS@163.COM.
Chinese Journal of Burns 2015;31(4):244-247
OBJECTIVETo analyze the development of liver damage and reactivation of hepatitis B virus (HBV) during the treatment of extremely severe burn injury in HBsAg positive patients, in order to provide reference for prevention and treatment of liver damage in patients with HBV infection after extremely severe burn.
METHODSMedical records of 54 HBsAg positive patients after extremely severe burn injury admitted from January 2004 to December 2014 were retrospectively analyzed. Development of liver damage and HBV reactivation of these patients during the treatment were analyzed according to the classification of their gender, results of hepatitis B e antigen (HBeAg) and HBV DNA examinations on admission, and development of sepsis in the process of treatment. Data were processed with chi-square test.
RESULTS(1) The incidence of liver damage in the process of treatment of these patients was 85.2% (46/54). Among all the patients, the proportion of liver damage was 35/38 in male, which was significantly higher than that in female (11/16, χ² = 4.867, P<0.05). Liver damage was found in all of 26 patients who were HBeAg positive on admission, 34 patients who were HBV DNA positive on admission, and 36 patients who developed sepsis in the process of treatment; the proportions were significantly higher than those in patients who were HBeAg negative on admission (20/28), patients who were HBV DNA negative on admission (12/20), and patients who did not develop sepsis in the process of treatment (10/18), with χ² values respectively 11.801, 18.384, and 20.574, P values below 0.01. (2) The incidence of HBV reactivation in these patients was 29.6% (16/54). Among all the patients, the proportion of HBV reactivation was 13/38 in male and 3/16 in female, with no statistically significant difference between them (χ² = 0.656, P>0.05). The proportions of HBV reactivation in patients who were HBeAg positive on admission, patients who were HBV DNA positive on admission, and patients who developed sepsis in the process of treatment were respectively 13/26, 16/34, and 15/36, and they were significantly higher than those in patients who were HBeAg negative on admission (3/28), patients who were HBV DNA negative on admission (0/20), and patients who did not develop sepsis in the process of treatment (1/18), with χ² values respectively 9.979, 18.615, and 5.873, P<0.05 or P<0.01.
CONCLUSIONSPatients who are HBsAg positive, HBeAg positive, HBV DNA positive on admission, and develop sepsis in the process of treatment of extremely severe burn injury are more likely to develop liver damage and HBV reactivation. It is necessary to dynamically monitor the changes in HBV DNA and liver function, in order to identity the reactivation of virus.
Alanine Transaminase ; blood ; Burns ; complications ; drug therapy ; Chemical and Drug Induced Liver Injury ; DNA, Viral ; Female ; Hepatitis Antibodies ; blood ; Hepatitis B ; drug therapy ; epidemiology ; virology ; Hepatitis B Surface Antigens ; blood ; immunology ; Hepatitis B virus ; drug effects ; immunology ; isolation & purification ; Hepatitis B, Chronic ; blood ; pathology ; virology ; Humans ; Incidence ; Liver ; pathology ; Male ; Retrospective Studies